The pro-FEIBA study: prophylactic dosing of Factor Eight Inhibitor Bypassing Activity (FEIBA) reduces bleeding frequency in haemophilia a patients with inhibitors

---

Copy For Citation

Gringeri A., Antmen B., Berntorp E., Biasioli C., Carpenter S., Kavakli K., ...More

HAEMOPHILIA, vol.17, no.2, pp.363, 2011 (SCI-Expanded)

• Publication Type: Article / Abstract
• Volume: 17 Issue: 2
• Publication Date: 2011
• Journal Name: HAEMOPHILIA
• Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
• Page Numbers: pp.363
• Istanbul University Affiliated: No